73.345 USD
+0.48 (+0.67%)
Overall DXCM gets a fundamental rating of 7 out of 10. We evaluated DXCM against 184 industry peers in the Health Care Equipment & Supplies industry. DXCM gets an excellent profitability rating and is at the same time showing great financial health properties. DXCM is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make DXCM a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
- In the past year DXCM was profitable.
- In the past year DXCM had a positive cash flow from operations.
- Each year in the past 5 years DXCM has been profitable.
- In the past 5 years DXCM always reported a positive cash flow from operatings.
1.2 Ratios
- DXCM has a Return On Assets of 9.61%. This is amongst the best in the industry. DXCM outperforms 92.93% of its industry peers.
- With an excellent Return On Equity value of 26.44%, DXCM belongs to the best of the industry, outperforming 97.28% of the companies in the same industry.
- DXCM's Return On Invested Capital of 15.72% is amongst the best of the industry. DXCM outperforms 95.65% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for DXCM is above the industry average of 8.84%.
- The 3 year average ROIC (11.25%) for DXCM is below the current ROIC(15.72%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.61% | ||
| ROE | 26.44% | ||
| ROIC | 15.72% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
1.3 Margins
- The Profit Margin of DXCM (15.96%) is better than 92.93% of its industry peers.
- DXCM's Profit Margin has improved in the last couple of years.
- DXCM's Operating Margin of 18.41% is amongst the best of the industry. DXCM outperforms 90.22% of its industry peers.
- DXCM's Operating Margin has improved in the last couple of years.
- DXCM's Gross Margin of 60.20% is fine compared to the rest of the industry. DXCM outperforms 61.41% of its industry peers.
- DXCM's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.41% | ||
| PM (TTM) | 15.96% | ||
| GM | 60.2% |
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
2. Health
2.1 Basic Checks
- DXCM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- DXCM has more shares outstanding than it did 1 year ago.
- DXCM has more shares outstanding than it did 5 years ago.
- DXCM has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 5.25 indicates that DXCM is not in any danger for bankruptcy at the moment.
- With a decent Altman-Z score value of 5.25, DXCM is doing good in the industry, outperforming 78.80% of the companies in the same industry.
- DXCM has a debt to FCF ratio of 2.36. This is a good value and a sign of high solvency as DXCM would need 2.36 years to pay back of all of its debts.
- With an excellent Debt to FCF ratio value of 2.36, DXCM belongs to the best of the industry, outperforming 85.33% of the companies in the same industry.
- DXCM has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
- With a Debt to Equity ratio value of 0.47, DXCM perfoms like the industry average, outperforming 44.02% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 2.36 | ||
| Altman-Z | 5.25 |
ROIC/WACC1.64
WACC9.61%
2.3 Liquidity
- DXCM has a Current Ratio of 1.56. This is a normal value and indicates that DXCM is financially healthy and should not expect problems in meeting its short term obligations.
- DXCM has a worse Current ratio (1.56) than 71.20% of its industry peers.
- A Quick Ratio of 1.38 indicates that DXCM should not have too much problems paying its short term obligations.
- With a Quick ratio value of 1.38, DXCM perfoms like the industry average, outperforming 40.22% of the companies in the same industry.
- DXCM does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 9.41% over the past year.
- The Earnings Per Share has been growing by 29.25% on average over the past years. This is a very strong growth
- DXCM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.21%.
- The Revenue has been growing by 22.27% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)9.41%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%35.56%
Revenue 1Y (TTM)14.21%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%21.64%
3.2 Future
- The Earnings Per Share is expected to grow by 22.05% on average over the next years. This is a very strong growth
- Based on estimates for the next years, DXCM will show a quite strong growth in Revenue. The Revenue will grow by 13.28% on average per year.
EPS Next Y27.38%
EPS Next 2Y23.51%
EPS Next 3Y22.59%
EPS Next 5Y22.05%
Revenue Next Year15.45%
Revenue Next 2Y14.08%
Revenue Next 3Y13.66%
Revenue Next 5Y13.28%
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- DXCM is valuated quite expensively with a Price/Earnings ratio of 39.43.
- Based on the Price/Earnings ratio, DXCM is valued a bit cheaper than the industry average as 70.65% of the companies are valued more expensively.
- DXCM's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.21.
- With a Price/Forward Earnings ratio of 29.14, DXCM can be considered very expensive at the moment.
- DXCM's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. DXCM is cheaper than 72.28% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 25.98, DXCM is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.43 | ||
| Fwd PE | 29.14 |
4.2 Price Multiples
- DXCM's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. DXCM is cheaper than 73.37% of the companies in the same industry.
- DXCM's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DXCM is cheaper than 82.07% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 26.94 | ||
| EV/EBITDA | 24.27 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The excellent profitability rating of DXCM may justify a higher PE ratio.
- DXCM's earnings are expected to grow with 22.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.44
PEG (5Y)1.35
EPS Next 2Y23.51%
EPS Next 3Y22.59%
5. Dividend
5.1 Amount
- No dividends for DXCM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
DEXCOM INC / DXCM FAQ
Can you provide the ChartMill fundamental rating for DEXCOM INC?
ChartMill assigns a fundamental rating of 7 / 10 to DXCM.
Can you provide the valuation status for DEXCOM INC?
ChartMill assigns a valuation rating of 5 / 10 to DEXCOM INC (DXCM). This can be considered as Fairly Valued.
Can you provide the profitability details for DEXCOM INC?
DEXCOM INC (DXCM) has a profitability rating of 9 / 10.
Can you provide the PE and PB ratios for DXCM stock?
The Price/Earnings (PE) ratio for DEXCOM INC (DXCM) is 39.43 and the Price/Book (PB) ratio is 10.49.